Citadel Advisors’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.4M | Buy |
|
|||||
|
2025
Q2 | $6.61M | Buy |
|
|||||
|
2025
Q1 | $1.25M | Sell |
|
|||||
|
2024
Q4 | $5.42M | Buy |
|
|||||
|
2024
Q3 | $5.61M | Sell |
|
|||||
|
2024
Q2 | $16.1M | Buy |
|
|||||
|
2024
Q1 | $5.05M | Sell |
|
|||||
|
2023
Q4 | $26.3M | Sell |
|
|||||
|
2023
Q3 | $45.7M | Buy |
|
|||||
|
2023
Q2 | $36.2M | Sell |
|
|||||
|
2023
Q1 | $46.6M | Sell |
|
|||||
|
2022
Q4 | $73M | Buy |
|
|||||
|
2022
Q3 | $60.3M | Sell |
|
|||||
|
2022
Q2 | $52M | Buy |
|
|||||
|
2022
Q1 | $34.3M | Buy |
|
|||||
|
2021
Q4 | $7.81M | Buy |
|
|||||
|
2021
Q3 | $1.62M | Sell |
|
|||||
|
2021
Q2 | $6.99M | Buy |
|
|||||
|
2021
Q1 | $5.18M | Buy |
|
|||||
|
2020
Q4 | $2.9M | Sell |
|
|||||
|
2020
Q3 | $4.65M | Buy |
|
|||||
|
2020
Q2 | $1.16M | Buy |
|
|||||
|
2020
Q1 | $882K | Sell |
|
|||||
|
2019
Q4 | $3.39M | Buy |
|
|||||
|
2019
Q3 | $448K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $289K | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $767K | Sell |
|
|||||
|
2018
Q1 | $2.17M | Sell |
|
|||||
|
2017
Q4 | $14.5M | Buy |
|
|||||
|
2017
Q3 | $12.4M | Buy |
|
|||||
|
2017
Q2 | $7.69M | Sell |
|
|||||
|
2017
Q1 | $7.88M | Buy |
|
|||||
|
2016
Q4 | $2.16M | Sell |
|
|||||
|
2016
Q3 | $6.34M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $166K | Sell |
|
|||||
|
2015
Q4 | $1.8M | Buy |
|
|||||
|
2015
Q3 | $1.88M | Sell |
|
|||||
|
2015
Q2 | $2.78M | Buy |
|